FR2292470B1 - - Google Patents

Info

Publication number
FR2292470B1
FR2292470B1 FR7536295A FR7536295A FR2292470B1 FR 2292470 B1 FR2292470 B1 FR 2292470B1 FR 7536295 A FR7536295 A FR 7536295A FR 7536295 A FR7536295 A FR 7536295A FR 2292470 B1 FR2292470 B1 FR 2292470B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7536295A
Other languages
French (fr)
Other versions
FR2292470A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2292470A1 publication Critical patent/FR2292470A1/fr
Application granted granted Critical
Publication of FR2292470B1 publication Critical patent/FR2292470B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7536295A 1974-11-27 1975-11-27 Nouvelles compositions pour le traitement de l'hyperlipidemie Granted FR2292470A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,560 US3969508A (en) 1974-11-27 1974-11-27 Lowering the concentration of plasma triglycerides

Publications (2)

Publication Number Publication Date
FR2292470A1 FR2292470A1 (fr) 1976-06-25
FR2292470B1 true FR2292470B1 (US20110158925A1-20110630-C00042.png) 1978-11-10

Family

ID=24101958

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7536295A Granted FR2292470A1 (fr) 1974-11-27 1975-11-27 Nouvelles compositions pour le traitement de l'hyperlipidemie

Country Status (10)

Country Link
US (1) US3969508A (US20110158925A1-20110630-C00042.png)
AU (1) AU499316B2 (US20110158925A1-20110630-C00042.png)
BE (1) BE835823A (US20110158925A1-20110630-C00042.png)
DE (1) DE2553101A1 (US20110158925A1-20110630-C00042.png)
FR (1) FR2292470A1 (US20110158925A1-20110630-C00042.png)
GB (1) GB1535203A (US20110158925A1-20110630-C00042.png)
IL (1) IL48518A (US20110158925A1-20110630-C00042.png)
NL (1) NL7513877A (US20110158925A1-20110630-C00042.png)
PH (2) PH11295A (US20110158925A1-20110630-C00042.png)
ZA (1) ZA757439B (US20110158925A1-20110630-C00042.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1569404A (en) * 1977-04-22 1980-06-11 Soc D Etudes Prod Chimique (2-isopropyl-4-(2'-theonyl)-5-methyl) phenoxy acetic acid
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
US3402198A (en) * 1965-10-20 1968-09-17 William A. Bolhofer 2-(phenoxy), 2-(phenylthio) and 2-(anilino) substituted 2-alkylideneacetic acid derivatives
GB1228236A (US20110158925A1-20110630-C00042.png) * 1968-05-20 1971-04-15
BE757001A (fr) * 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation

Also Published As

Publication number Publication date
NL7513877A (nl) 1976-05-31
FR2292470A1 (fr) 1976-06-25
PH12855A (en) 1979-09-12
ZA757439B (en) 1976-11-24
PH11295A (en) 1977-11-02
IL48518A0 (en) 1976-01-30
AU499316B2 (en) 1979-04-12
GB1535203A (en) 1978-12-13
DE2553101A1 (de) 1976-08-12
BE835823A (fr) 1976-05-21
US3969508A (en) 1976-07-13
IL48518A (en) 1978-08-31
AU8689475A (en) 1977-06-02

Similar Documents

Publication Publication Date Title
FR2261781A1 (US20110158925A1-20110630-C00042.png)
JPS50114738A (US20110158925A1-20110630-C00042.png)
FR2292470B1 (US20110158925A1-20110630-C00042.png)
FR2277929B3 (US20110158925A1-20110630-C00042.png)
FR2281032B1 (US20110158925A1-20110630-C00042.png)
JPS50104704A (US20110158925A1-20110630-C00042.png)
JPS50119134A (US20110158925A1-20110630-C00042.png)
JPS50127433U (US20110158925A1-20110630-C00042.png)
JPS50119122U (US20110158925A1-20110630-C00042.png)
JPS50128572U (US20110158925A1-20110630-C00042.png)
JPS50136160U (US20110158925A1-20110630-C00042.png)
BG22303A1 (US20110158925A1-20110630-C00042.png)
CH571710A5 (US20110158925A1-20110630-C00042.png)
BG21312A1 (US20110158925A1-20110630-C00042.png)
BG21623A1 (US20110158925A1-20110630-C00042.png)
BG21710A1 (US20110158925A1-20110630-C00042.png)
BG22518A1 (US20110158925A1-20110630-C00042.png)
CH1340175A4 (US20110158925A1-20110630-C00042.png)
CH1446574A4 (US20110158925A1-20110630-C00042.png)
CH231275A4 (US20110158925A1-20110630-C00042.png)
CH238674A4 (US20110158925A1-20110630-C00042.png)
CH563833A5 (US20110158925A1-20110630-C00042.png)
BG20884A1 (US20110158925A1-20110630-C00042.png)
BG20746A1 (US20110158925A1-20110630-C00042.png)
BG20501A1 (US20110158925A1-20110630-C00042.png)

Legal Events

Date Code Title Description
ST Notification of lapse